Next, we checked the prognostic significance of BIRC5 in breast cancer and demonstrated that high BIRC5 expression was responsible for shorter relapse-free survival, worse overall survival, reduced distant metastasis-free survival, and increased risk of metastatic relapse event. Here, BIRC5 is linked to breast carcinoma.